The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

6 pts

Opinion on  Cubist Pharmaceuticals Inc. (CBST)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
EU approves Cubicin

Nov 14, 2008 05:54 PM GMT
20105205_1_
Return Risk
+16.88% LOW
Analyst

EU approves Novartis' Cubicin to treat hospital infections

FDLI SmartBrief | 11/07/2008

The European Union has approved Cubicin for expanded use in patients suffering from potentially fatal infections commonly contracted during hospital stays. The two new indications approved were right-sided infective endocarditis due to Staphylococcus aureus, an infection of the heart valve, and Staphylococcus aureus bacteremia, a bloodstream infection. Reuters (09/05)


CBST:  This call was made on 11/14/08 @ $24.8
Rating:   Positive   $24.8 (11/14/08)
Gain/Loss:   -31.21% in 358 days


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +35.25% 368
2 Gerald Greene 18.14 +70.90% 206
3 stockmarketfunding.com 17.66 +25.78% 53
4 akiralegrand 13.47 +14.32% 60
5 anup2104 12.13 +69.23% 34


POPULAR STOCKS
Symbol Company Name Sentiment
CSCO Cisco Systems Inc
MCD McDonald's Corp.
LEH Lehman Brothers Holdings Inc
BA The Boeing Company
WMT WalMart Stores Inc
GOOG Google Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Cubist Pharmaceuticals Inc. (CBST)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by ariesdragon
Symbol SP Sentiment Rating Return Since
AGU Positive +43.46% 01/29/09
MUR Positive +32.02% 01/29/09
OXY Positive +39.62% 01/29/09
NJR N/A Positive -11.56% 01/29/09
DTV Positive +35.58% 11/24/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch